Posted by Michael Wonder on 14 Jun 2025
NICE leads the way in approving breakthrough treatment for multiple myeloma
13 June 2025 - People in England will become the first in the world to receive belantamab mafodotin for this indication following our recommendation and the UK's MHRA approval earlier this year.
Around 1,500 people with multiple myeloma are set to benefit from the treatment, which combines belantamab mafodotin (Blenrep) with bortezomib and dexamethasone.
